{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T10:47:58Z","timestamp":1772275678962,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ucl.2009.11.004","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T05:22:33Z","timestamp":1265174553000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prostate Cancer: To Screen or Not to Screen?"],"prefix":"10.1016","volume":"37","author":[{"given":"Alex","family":"Shteynshlyuger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald L.","family":"Andriole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ucl.2009.11.004_bib1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMe0901166","article-title":"Screening for prostate cancer\u2014the controversy that refuses to die","volume":"360","author":"Barry","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ucl.2009.11.004_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eururo.2009.04.026","article-title":"Prostate cancer screening: the need for problem-solving that puts men's interests first","volume":"56","author":"Holmberg","year":"2009","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2009.11.004_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-149-3-200808050-00008","article-title":"Screening for prostate cancer: U.S. preventive services task force recommendation statement","volume":"149","author":"U.S. Preventive Services Task Force","year":"2008","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.ucl.2009.11.004_bib4","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ucl.2009.11.004_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ucl.2009.11.004_bib6","unstructured":"Horner MJ, Ries LAG, Krapcho M, et al, editors. SEER Cancer statistics review, 1975\u20132006. Bethesda (MD): National Cancer Institute. Table 23.9: cancer of the prostate. Available at: http:\/\/seer.cancer.gov\/csr\/1975_2006\/index.html. Accessed October 15, 2009."},{"issue":"9","key":"10.1016\/j.ucl.2009.11.004_bib7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1046\/j.1464-410x.2000.00679.x","article-title":"Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden","volume":"85","author":"Hugosson","year":"2000","journal-title":"BJU Int"},{"issue":"16","key":"10.1016\/j.ucl.2009.11.004_bib8","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jnci\/djn255","article-title":"Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial","volume":"100","author":"Bill-Axelson","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ucl.2009.11.004_bib9","first-page":"509","article-title":"Quality of life of men treated for localized prostate cancer: outcomes at 6 and 12 months","volume":"17","author":"Lev","year":"2009","journal-title":"Support Care Cancer"},{"issue":"suppl 7","key":"10.1016\/j.ucl.2009.11.004_bib10","first-page":"S86","article-title":"The psychological aftermath of prostate cancer treatment choices: a comparison of depression, anxiety and quality of life outcomes over the 12 months following diagnosis","volume":"190","author":"Couper","year":"2009","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.ucl.2009.11.004_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.1995.03520260051032","article-title":"Quality-of-life outcomes in men treated for localized prostate cancer","volume":"273","author":"Litwin","year":"1995","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ucl.2009.11.004_bib12","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/cncr.22676","article-title":"Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer","volume":"109","author":"Litwin","year":"2007","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ucl.2009.11.004_bib13","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ucl.2009.11.004_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2008.08.054","article-title":"Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial","volume":"55","author":"Johansson","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ucl.2009.11.004_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnci\/djp001","article-title":"Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context","volume":"101","author":"Draisma","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.ucl.2009.11.004_bib16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/jnci\/djp278","article-title":"Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986\u20132005","volume":"101","author":"Welch","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.ucl.2009.11.004_bib17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.urology.2007.07.019","article-title":"Characteristics of prostate cancer detected by digital rectal examination only","volume":"70","author":"Okotie","year":"2007","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2009.11.004_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.eururo.2008.03.104","article-title":"The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam","volume":"54","author":"Gosselaar","year":"2008","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2009.11.004_bib19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0022-5347(17)49828-4","article-title":"Adenocarcinoma of the prostate: results of routine urological screening","volume":"132","author":"Thompson","year":"1984","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2009.11.004_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1464-410X.2006.06325.x","article-title":"Importance of peripheral biopsies in maximizing the detection of early prostate cancer in repeat 12-core biopsy protocols","volume":"98","author":"Philip","year":"2006","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2009.11.004_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.urology.2007.07.068","article-title":"Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation","volume":"70","author":"Pepe","year":"2007","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ucl.2009.11.004_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-5347(05)00211-9","article-title":"Saturation technique does not improve cancer detection as an initial prostate biopsy strategy","volume":"175","author":"Jones","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2009.11.004_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng\/ml or lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ucl.2009.11.004_bib24","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ucl.2009.11.004_bib25","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0090-4295(02)01958-1","article-title":"Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program","volume":"60","author":"Raaijmakers","year":"2002","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2009.11.004_bib26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0022-5347(05)65851-X","article-title":"Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study [review]","volume":"166","author":"Djavan","year":"2001","journal-title":"J Urol"},{"issue":"19","key":"10.1016\/j.ucl.2009.11.004_bib27","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/jnci\/djm153","article-title":"Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence","volume":"99","author":"Haas","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ucl.2009.11.004_bib28","article-title":"Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer","author":"Seitz","year":"2009","journal-title":"Urol Oncol"},{"issue":"9","key":"10.1016\/j.ucl.2009.11.004_bib29","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3109\/02841850903216718","article-title":"Prostate cancer detection: the value of performing an MRI before a biopsy","volume":"50","author":"Shimizu","year":"2009","journal-title":"Acta Radiol"},{"issue":"4","key":"10.1016\/j.ucl.2009.11.004_bib30","first-page":"220","article-title":"Prostate cancer: current evidence weighs against population screening","volume":"59","author":"Boyle","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ucl.2009.11.004_bib31","series-title":"Bureau, statistical abstract of the United States: 2009","author":"U.S. Census","year":"2008"},{"key":"10.1016\/j.ucl.2009.11.004_bib32","article-title":"Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendations","author":"Nguyen","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"30","key":"10.1016\/j.ucl.2009.11.004_bib33","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1200\/JCO.2008.21.2613","article-title":"Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort","volume":"27","author":"Shappley","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014309001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014309001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:21:11Z","timestamp":1758806471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014309001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0094014309001062"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2009.11.004","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate Cancer: To Screen or Not to Screen?","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2009.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}